Severe and Difficult‐to‐Treat Asthma in Adults

@article{Israel2017SevereAD,
  title={Severe and Difficult‐to‐Treat Asthma in Adults},
  author={E. Israel and H. Reddel},
  journal={The New England Journal of Medicine},
  year={2017},
  volume={377},
  pages={965–976}
}
  • E. Israel, H. Reddel
  • Published 2017
  • Medicine
  • The New England Journal of Medicine
    • Adults with severe asthma consume substantial human and financial resources. This review examines the biology, current diagnosis, and treatment of this multifaceted condition. 
    View on Wolters Kluwer
    dickyricky.com
    Top 3 of 147 Citations
    Escalating Inhaled Glucocorticoids to Prevent Asthma Exacerbations.
    P. BardinThe New England journal of medicine2018
    5
    Variability of blood eosinophils in patients in a clinic for severe asthma
    E. Rakowski, S. Zhao, … J. ReibmanClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2019
    4
    Severe asthma in Australia Diagnosis of severe asthma
    T. R. Tay, Joy W Lee, M. Hew2018

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
    The primary objective of this study is to evaluate several interventions given to participants with severe asthma. Interventions are administered in a crossover manner with 16-week… Expand
    ConditionsAsthma
    InterventionDrug, Other
    University of North Carolina, Chapel Hill
    November 2019 - June 2023
    147 Citations
    Fields of Study

    Fields of Study

    Citation Type

    Citation Type

    Escalating Inhaled Glucocorticoids to Prevent Asthma Exacerbations.
    5
    Variability of blood eosinophils in patients in a clinic for severe asthma
    4
    Severe asthma in Australia Diagnosis of severe asthma
    Severe asthma in Australia Managing comorbid conditions in severe asthma
    Involvement of the epidermal growth factor receptor in IL‐13–mediated corticosteroid‐resistant airway inflammation
    2
    Asthma: newer Tx options mean more targeted therapy.
    Addressing Comorbidities in Difficult Asthma
    Update on Diagnosis and Management of Severe Asthma
    Integrating Type 2 Biologics in the Management of Uncontrolled Severe Asthma: The Importance of Lung Function in Disease Control
    Biological treatments for severe asthma: where do we stand?
    14

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 55 REFERENCES
    Three phenotypes of adult‐onset asthma
    113
    The Asthma-COPD Overlap Syndrome.
    364
    Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial
    241
    Therapeutic interventions in severe asthma
    34
    Mepolizumab for Severe Eosinophilic Asthma (DREAM): A Multicentre, Double-Blind, Placebo-Controlled Trial
    451
    The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
    105
    Noneosinophilic asthma: a distinct clinical and pathologic phenotype.
    237
    Lung imaging in asthmatic patients: the picture is clearer.
    81
    Refractory asthma: mechanisms, targets, and therapy
    86
    International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
    1753